Zoe

Where to start with an Australian legal problem: plain-English guides, with the legislation and case law behind them.

Platform

Legislation
Cases
Guides
Find a lawyer
Absurdities
Ask Zoe
Graph
Recently analysed

Free tools

Bond claim checker
Barking dog and noise diary
Support at Home statement check
All tools

Lawyers: our picks

Zoe

Where to start with an Australian legal problem: plain-English guides, with the legislation and case law behind them.

Platform

Legislation
Cases
Guides
Find a lawyer
Absurdities
Ask Zoe
Graph
Recently analysed

Free tools

Bond claim checker
Barking dog and noise diary
Support at Home statement check
All tools

Lawyers: our picks

Lawyers in Sydney
Lawyers in Melbourne
Lawyers in Brisbane
Lawyers in Perth
Family lawyers
Employment lawyers
Criminal lawyers
Wills and estates lawyers
Find a lawyer

Company

Pricing
API
Privacy
Terms
Support
X
LinkedIn
Instagram

Jurisdictions

Commonwealth
New South Wales
Queensland
Victoria
Western Australia
South Australia
Tasmania
Australian Capital Territory
Northern Territory

Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.

Section 3 - Treatment Benefits (Special Access) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2019 - Authority | Zoe

Zoe

Legislation Cases Guides Find a lawyer Absurdities Ask Zoe Graph Pricing

Ask Zoe →

Home/Legislation/Treatment Benefits (Special Access) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2019/3

CTHIn ForceLegislation

Treatment Benefits (Special Access) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2019

3Authority

Start here

Get a plain-English read of 3

Turn the raw legal text into a practical explanation grounded in Treatment Benefits (Special Access) (Modifications of the Repatriation Pharmaceutical Benefits Scheme) Instrument 2019.

Ask Zoe about this section View in full context

3 Authority

This instrument is made under section 20 of the Treatment Benefits (Special Access) Act 2019.

Previous section2Commencement

Next section4Schedule—Modifications of the Repatriation Pharmaceutical Benefits Scheme